PCHPI Collaboration Development Award Program
The application deadline has passed. Please check back in the summer of 2024.
Eligible Investigators: Early career, independent HIV-1 investigators as well as investigators at any career stage who have not previously worked on HIV-1. Faculty with more than US$500,000, or equivalent, in annual direct cost funding will not be eligible.
Required Components for the Application (in indicated order):
- PCHPI Cover Page (contact Teresa Brosenitsch, tab24@pitt.edu, to obtain form)
- Abstract
- Detailed Budget and Budget Justification
- NIH Biosketch (5 page maximum)
- Proposal Text (sections A – E, 6 pages maximum)
- A. Specific Aim(s)
- B. Significance
- C. Innovation
- D. Approach, including a consideration of Scientific Rigor and Reproducibility
- E. Timeline and Specific Milestone(s)
- F. References Cited
- List of current and pending support from all sources
Letters of collaboration should only be included if a collaborator will be conducting specific experiments that are described in the proposal or providing required reagents, equipment, or access to facilities.
Format: Single-spaced, 1/2 inch (1.27 cm) margins, arial typeface, and a font size of 11 points or larger (or similar NIH-compliant format)
Submission: All proposals should be submitted electronically, as a single PDF file, to Dr. Teresa Brosenitsch, PCHPI coordinator, at tab24@pitt.edu.
Questions: Questions about the application and review processes should be directed to Dr. Teresa Brosenitsch at tab24@pitt.edu or 412-648-8968.
Funded Individuals:
All funded investigators will be required to follow all NIH regulations/requirements, including those related to animal use, human subjects, and recombinant DNA. In addition, participation in PCHPI activities, including web-based monthly work-in-progress meetings and annual symposia, is required.
Funded investigators will also participate in the PCHPI Mentored Scientist Program, through which the applicant will be paired with a PCHPI member or collaborator whose research is complementary to that of the funded investigator.